Clinical Trials Directory

Trials / Unknown

UnknownNCT01073137

Noninvasive Blood Glucose Monitoring Using Otoacoustic Emissions

Status
Unknown
Phase
Study type
Observational
Enrollment
44 (estimated)
Sponsor
Portland VA Medical Center · Federal
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of the research is to determine whether a noninvasive hearing test may be used to predict blood glucose in people with diabetes.

Detailed description

Participation in the study will involve listening to sounds through earphones while blood glucose levels are measured by taking blood samples using a lancet. During the study, blood glucose levels will be increased by drinking a beverage containing sugar. Up to five visits to the NCRAR will be needed over a six-month period to complete the study. Each visit lasts either two or four hours, and will be scheduled at your convenience. You will be paid $20 for the first 2-hour screening visit and $50 for each 4-hour visit. You will be paid $30 if you are selected to participate in a 2-hour Attention Correlation Test that a sub-set of 10 participants will complete.

Conditions

Timeline

Start date
2006-06-01
Primary completion
2010-06-01
Completion
2010-06-01
First posted
2010-02-23
Last updated
2010-02-23

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01073137. Inclusion in this directory is not an endorsement.

Noninvasive Blood Glucose Monitoring Using Otoacoustic Emissions (NCT01073137) · Clinical Trials Directory